Torrent Pharmaceuticals Limited — Board Meeting, 28-07-2025: Outcome of Board Meeting

Torrent Pharma's board approved the financial results for the quarter ended June 30, 2025. The company posted strong consolidated performance with revenue reaching ₹3,178 Cr, up 11% year-on-year, and net profit climbing 20% to ₹548 Cr. Key markets like India (+11%), Brazil (+11%), and the US (+19%) drove robust sales.

Strategically, the board approved plans to raise funds via Non-Convertible Debentures through private placement. A significant development is the proposed acquisition of a controlling stake in JB Pharma for approximately ₹11,917 Cr, which will involve an open offer and eventual merger, subject to approvals.